poisar

Stocks · News reference

Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate

BenzingaAug 11, 2026, 11:11 AMBenzinga Newsdesk

Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.32) by 40.63 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the same

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 11, 2026, 11:11 AM
Checked
Aug 11, 2026, 11:11 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 19, 2026, 9:00 PMSEC EDGAR

    8-K filing — Neuraxis, INC (NRXS)

    Filed: 2026-08-19 AccNo: 0001493152-26-039247 Size: 204 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events

    Read original at edgar